Shionogi & Co. lifted its full-year profit guidance as expected royalties from its HIV treatment surpass prior expectations.
Share
Read more
Bloomberg - Where voices unite, stories flourish, and community thrives through open dialogue and meaningful connections.
Company
Trending
Categories
© Bloombergnews. All rights resereved